SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-032410
Filing Date
2024-08-14
Accepted
2024-08-14 17:15:41
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 2286002
2 ex31-1.htm EX-31.1 11949
3 ex31-2.htm EX-31.2 12233
4 ex32-1.htm EX-32.1 7997
5 ex32-2.htm EX-32.2 7942
6 form10-q_001.jpg GRAPHIC 13285
  Complete submission text file 0001493152-24-032410.txt   9252960

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE mgrx-20240630.xsd EX-101.SCH 52284
8 XBRL CALCULATION FILE mgrx-20240630_cal.xml EX-101.CAL 58604
9 XBRL DEFINITION FILE mgrx-20240630_def.xml EX-101.DEF 270982
10 XBRL LABEL FILE mgrx-20240630_lab.xml EX-101.LAB 473347
11 XBRL PRESENTATION FILE mgrx-20240630_pre.xml EX-101.PRE 380552
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1121190
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

IRS No.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41615 | Film No.: 241209541
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)